The 2024 amendments simplified Form 27 and the in-house community exhaled. No more annual filing. No more revenue disclosure. No more value derived field. The new cycle runs once every three financial years. The reason for non-working is now a tick box. The whole exercise was supposed to become a compliance afterthought.
That is exactly what makes it dangerous.
Nothing the 2024 amendment did changes what Form 27 India actually is. It is a sworn statement filed on a public record certifying the commercial working of a granted monopoly. The simplification reduced what the patentee has to say. It did not reduce the legal weight of saying it, the criminal exposure attached to saying it incorrectly, or the evidentiary consequences of what the record shows when a compulsory licence applicant reads it three years later.
The Three Statutory Facts That Did Not Change
The in-house teams celebrating the Form 27 simplification should know three statutory facts that the 2024 amendment left entirely untouched.
The first is Section 122(2) of the Patents Act, 1970. A false statement made in Form 27, including ticking the wrong box on working status, exposes the signatory to imprisonment up to six months, a fine, or both. The form was simplified. The criminal liability was not. The General Counsel or company secretary who signs Form 27 as a routine compliance exercise is putting their name on a criminal liability instrument. That has not changed.
The second is Section 122(1)(b), which imposes a fine of up to ten lakh rupees per patent for non-filing. For a portfolio of fifty patents, that exposure is five crore rupees and it is not theoretical. Portfolios of that scale are common across pharmaceutical, technology, and consumer goods sectors in India. A General Counsel who treats Form 27 as administrative overhead may be signing off on a penalty exposure in that range in the same hour she signs supplier contracts that would never go out without substantive legal review.
The third statutory fact is the one the boardroom never sees coming. Form 27 filings are public documents. They are pulled, read forensically, and cited as evidence in compulsory licence applications and Section 85 revocation proceedings. The working statement record a patentee builds over the life of the patent becomes the evidentiary foundation that opponents use to challenge the patent’s survival. The simplification of the form did not change that use. It made the form easier to file carelessly, which makes the evidentiary exposure worse, not better.
The Natco v. Bayer Precedent and What It Means for Every Patent Portfolio
The first Indian compulsory licence, granted in 2012 in Natco Pharma Ltd. v. Bayer Corporation, IPAB Order No. 45 of 2013, is the governing precedent for how working statement disclosures interact with compulsory licence proceedings. Every patentee filing Form 27 in India should have read it.
The Controller examining the Natco application assessed three grounds under Section 84. Whether the reasonable requirements of the public had been satisfied. Whether the patented invention was available at a reasonably affordable price. Whether the patent was worked in the territory of India. On the third ground, the Controller examined whether Bayer had worked the patent to the fullest extent reasonably practicable. The working statement disclosures were central to the analysis. The absence of demonstrable Indian manufacturing was a significant factor in the reasoning. The compulsory licence was granted.
The Bayer defence, that the patent was worked through imports rather than domestic manufacturing, did not persuade the bench. Subsequent jurisprudence has continued to read working as a substantive requirement. Indian-territory working, not global commercialisation, is what the statute asks about and what the form addresses.
The evidentiary consequence for every patentee is direct. A casual yes, working, on a patent that has not generated a rupee in Indian territory is the gift that funds the other side’s pleading in a compulsory licence application. A no, not worked, with a reason for non-working that does not stand commercial scrutiny, is the same gift differently wrapped. The applicant’s lawyer pulls every Form 27 ever filed for the patent family and reads them forensically. The inconsistency between the working declaration and the commercial reality is the foundation of the Section 84 pleading.
The Group Filing Risk the 2024 Amendment Created
The 2024 amendment introduced a procedural convenience that carries a structural risk most patentees have not fully absorbed. Group filing is now permitted for related patents. A single declaration can cover multiple patents in the same family.
The administrative ease is real and for large portfolios the reduction in filing burden is significant. The contamination risk is equally real. A single careless declaration now infects an entire patent family in a single filing. One incorrect working status ticked across a family of twenty patents creates twenty instances of the same evidentiary problem, and those twenty instances are all on the public record simultaneously.
Patentees who are using group filing as an efficiency measure need to ensure that the efficiency applies to the filing process, not to the substantive review of what each patent in the group actually discloses about commercial working. The pre-filing audit discipline that Form 27 has always required is more important, not less important, when a single declaration covers a family of commercially significant patents.
The Three Portfolio Hygiene Rules
For patentees managing Form 27 India filings across a portfolio, three rules of practice apply consistently and their absence creates consistent exposure.
The first is a pre-filing audit by counsel rather than by the agent who files the form. The distinction matters. The agent’s job is to fill the boxes correctly according to what the client provides. Counsel’s job is to ask whether the box being filled is defensible if a compulsory licence applicant or revocation petitioner cites it back to the patentee in three years. The two perspectives require different questions. Counsel asking whether the working declaration matches the commercial reality is doing different work from an agent confirming that the form is complete. Both are necessary. Only counsel’s review protects against the strategic use of the filing.
The second rule is a documentary basis for every working tick, assembled and retained at the time of filing. Supply agreements, invoices, licence records, manufacturing logs, distribution agreements with Indian parties. Not assembled later under subpoena or in response to an information request in litigation proceedings. By the time the missing documentation becomes urgent, the missing piece is the piece the other side needs. The document that demonstrates Indian territory working needs to exist before the form is filed and it needs to be retained in a form that can be produced under the pressure of litigation discovery.
The third rule is a reason for non-working that matches the commercial reality on the ground rather than the reason that sounded least embarrassing the morning the form was due. The reason for non-working is now a tick box with limited options under the amended form. The limited options create the temptation to select the option that sounds most defensible rather than the one that is most accurate. Pick the truest one. The bench reading the compulsory licence petition will examine both the declaration and the commercial reality behind it. The distance between the two is what the opponent’s pleading lives in.
The Offensive Use That Most Patentees Miss
There is a strategic dimension to Form 27 that the in-house community almost never discusses, and its absence from standard portfolio management practice is a commercial error.
Form 27 is not only a defensive compliance filing. It is an offensive evidentiary tool when it is used correctly. A patentee facing infringement in India who has filed clean, defensible working statements showing genuine commercial use in Indian territory argues injunction relief from a meaningfully stronger position than one whose working statement record is patchy, evasive, or inconsistent with the commercial evidence the patentee puts before the court.
The court reads the working statement record as part of the equitable balance at the interim injunction stage. The patentee who can demonstrate Indian territory working is the patentee whose injunction reads as proportionate. The court is being asked to protect a commercial interest that the patentee has demonstrably exercised in India. The patentee whose working statement record is thin is arguing equity uphill, asking for protection of an interest the public record suggests has not been actively exercised.
The same logic operates for foreign multinationals enforcing in India against domestic competitors. Defendant’s counsel will pull the Form 27 record and deploy any disconnect between the enforcement posture and the working declarations as leverage at the interim stage and at trial. The cleanest enforcement case is the case where the working statement record matches the commercial reality on the ground and both match the evidence the patentee puts before the court. That alignment is built over years of disciplined Form 27 practice. It cannot be constructed at the litigation stage.
What Foreign Associates Must Tell Their Clients
For foreign associates advising multinational clients on Indian patent strategy, Form 27 India has no equivalent in most home jurisdictions and the difference is not a technicality.
United States practice has no working requirement. European practice has no working statement filing regime. The casual approach to compliance that is entirely appropriate in those jurisdictions is malpractice in India, where the working statement is a public document, a criminal liability instrument, and a compulsory licence evidence repository simultaneously.
The 2024 simplification has made the Form 27 obligation easier to forget. The three-year cycle, the tick-box format, and the removal of the revenue disclosure field all reduce the administrative visibility of the filing obligation. They also reduce the professional attention it receives. Foreign associates who updated their India compliance checklists when the amendment came into force and filed the simplified forms without reviewing what the simplification preserved are carrying clients into the compulsory licence risk that the Natco v. Bayer precedent created and that subsequent jurisprudence has confirmed.
Warn the client. Run the audit. Ensure the documentary basis for every working tick is on file before the form is submitted. The form got simpler. The stakes did not.
